Toggle Nav
Close
  • Menu
  • Setting

Anti-TNFRSF10B/TRAILR2/CD262 Antibody (Lexatumumab)

Catalog No.
F1047
Anti-TNFRSF10B/TRAILR2/CD262 Antibody (Lexatumumab)
Grouped product items
SizePriceStock Qty
100ug
$69.00
Ship with 3-5 days
1mg
$206.00
Ship with 3-5 days
5mg
$577.00
Ship with 3-5 days
50mg
$1,931.00
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Lexatumumab (HGS-ETR 2) is a human IgG1 monoclonal antibody that agonizes TRAIL receptor 2 (TRAIL-R2, DR5, APO-2). Lexatumumab induces apoptosis in malignant mesothelioma. Lexatumumab can be used in the study of malignant pleural mesothelioma (MPM).

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

143.48 kDa

Shipping

Dry ice

Cas No.

845816-02-6

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

ETR2-ST01, HGS-ETR2, HGS1018

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

O14763

Reactivity

Human, Mouse

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

Immobilized human TNFRSF10B/TRAILR2 / CD262, Fc Tag at 2 ug/mL can bind lexatumumab

Target

TNFRSF10B / TRAILR2 / CD262

Note

Please avoid freeze-thaw cycles.